RevitaLash(R) Cosmetics Maintains Tireless Commitment to Breast Cancer Awareness

Press Releases »
          - Annual Brand Pink Campaign Supporting Breast Cancer Kicks Off with Global Giving

          A proud supporter of year-round breast cancer initiatives, RevitaLash(R) Cosmetics has debuted its annual Pink promotion, which began August 1st, 2018 and will continue through October to support and celebrate Breast Cancer Awareness month. The limited edition collection consists of the award-winning and coveted RevitaLash(R) Advanced (3.5mL) or RevitaBrow(R) Advanced (3.0 mL) housed in a luxury, white cosmetic bag with the celebrated pink ribbon.

          Through this campaign, RevitaLash Cosmetics Founder and CEO, Michael Brinkenhoff, M.D. honors and carries on the legacy of his late wife, who was diagnosed with metastatic breast cancer at the age of 32. The brand donates a portion of the proceeds from RevitaLash Cosmetic sales year-round.

          "Philanthropy has always been at the heart of the RevitaLash Cosmetics brand. We are very proud of our legacy and honor it with ongoing support for breast cancer awareness as part of our Eternally Pink pledge. It is so near and dear to the entire RevitaLash Cosmetics family," says Dr. Brinkenhoff.

          This year, RevitaLash Cosmetics is expanding their philanthropic footprint with a global giving strategy. From now through October 2018, $2 from the sale of each Pink promotion gift set will be donated to breast cancer awareness, research and education initiatives worldwide up to a maximum of $50,000. Also, for every eyelash and eyebrow conditioner sold on http://revitalash.com/ from September 15th2018 - October 31st 2018, the company will donate one RevitaBrow(R) Advanced to the City of Hope Positive Image Center up to a maximum of 1,600 units.

          This limited edition offer is available on shelves in select spas, salons and specialty retailers and online at http://revitalash.com/.

          About RevitaLash Cosmetics
          RevitaLash Cosmetics is a worldwide leader in developing advanced lash, brow and hair beautification products. Established in 2006, the collection includes award-winning RevitaLash(R) Advanced Eyelash Conditioner and RevitaBrow(R) Advanced Eyebrow Conditioner, and is available in over 10,000 physician's offices, spas, salons, and specialty retailers worldwide. A supporter of non-profit breast cancer initiatives, RevitaLash Cosmetics donates a portion of proceeds to research and education initiatives, giving back to the breast cancer community year-round, not just in October. For information, visit www.revitalash.com. [RevitaLash Advanced is not available in California.]

          Logo - https://mma.prnewswire.com/media/653485/RevitaLash_Cosmetics_Logo.jpg



ข่าวbreast cancer+RevitaLashวันนี้

RevitaLash(R) Cosmetics Launches Global and Local Impact Initiative in the Fight Against Breast Cancer

The Mission-Driven Lash & Brow Leader Continues Its Year-Round Breast Cancer Awareness Efforts RevitaLash(R) Cosmetics is proud to announce the company's annual Pink mission to make an impact in the fight against breast cancer. This initiative aims to provide both global and local support to organizations dedicated to breast cancer treatment, research, and education. RevitaLash(R) Cosmetics, renowned for its innovative lash, brow, and hair beautification products, has a heartfelt origin. It

RevitaLash(R) Cosmetics Champions Breast Cancer Awareness, Research, and Support Worldwide with 2022 Pink Program Announcement

The Mission-Driven Lash & Brow Leader Expands Its Year-Round Breast Cancer Awareness Efforts Globally RevitaLash(R) Cosmetics is proud to announce the company's annual 2022...

RevitaLash(R) Cosmetics Announces New Additions to Annual Program Benefiting Breast Cancer Awareness

- Brand Expands Year-Round Breast Cancer Awareness Efforts with 2020 Pink Program In addition to their ongoing year-round support and commitment to breast cancer awareness, RevitaLash(R) Cosmetics...

Cancer remains one of the most pressing h... AXA Strengthens Cancer Awareness and Prevention Efforts in Thailand — Cancer remains one of the most pressing health challenges in Thailand, with over 180...

Bangkok Dusit Medical Services Public Com... BDMS Launches Breast Cancer Screening Campaign to Promote Early Detection and Prevention — Bangkok Dusit Medical Services Public Company Limited (BDMS), a...

Kexing Biopharm Introduces Eribulin Mesylate Injection, Expanding Its Overseas Product Portfolio

On the morning of January 3, Kexing Biopharm signed an international commercialization cooperation agreement on Eribulin Mesylate Injection , securing exclusive commercialization licensing and supply of...

Menarini Group and Insilico Medicine Enter Global Exclusive License Agreement for Novel KAT6 Inhibitor for Potential Breast Cancer Treatment and Other Oncology Indications

KAT6 is an emerging target in hormone sensitive breast tumors and other cancers. Overexpression of KAT6A/B correlates with poor...